On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Exbio Praha AS's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.1M · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- NANOFOLPartner
Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€418ktheir share - SYBILLAPartner
Systems Biology of T-cell Activation in Health and Disease
FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗
€666ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNONetherlands · 1 shared project
- Albert-Ludwigs-Universitaet FreiburgGermany · 1 shared project
- Medizinische Universitaet WienAustria · 1 shared project
- Technische Universitaet GrazAustria · 1 shared project
- Turun YliopistoFinland · 1 shared project
- Deutsches Krebsforschungszentrum HeidelbergGermany · 1 shared project
- Universitaet Fuer Bodenkultur WienAustria · 1 shared project
- Universidade do MinhoPortugal · 1 shared project
- Medizinische Universitat InnsbruckAustria · 1 shared project
- Otto-Von-Guericke-Universitaet MagdeburgGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- arteriosclerosis
- autoimmune diseases
- cell signaling
- inflammatory diseases
- multiple sclerosis
- nanotechnology
- rheumatology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
